We prepared whole-blood pools to contain various concentrations of phenylalanine (Phe), thyroxin (T4), and thyrotropin (TSH) and applied them to six different lots of Schleicher & Schuell Grade 903 filter paper, two of which represented extremes for serum-absorbancy. Individual measured T4 values showed minimal overlap among all pools for each individual filter-paper lot and for all lots combined, but Phe values overlapped considerably among the high-concentration pools within and among lots. Individual TSH values also showed considerable overlap among the high-concentration pools for all lots combined, but little overlap within each lot.
analytes,
mixing it overnight with serum (4 g of charcoal per 100 mL of serum). Most of the charcoal was removed by centrifugation, the last traces of charcoal being removed by sequential ifitration through Millipore filters with 3.0-, 1.2-, 0.8-, 0.65-, 0.3-, and 0.2-sm-diameter pores. The treated serum was stored frozen at -20 #{176}C.
Erythrocytes. To wash erythrocyte preparations, we added 200 mL of saline (NaC1, 9 gIL) to a bag containing about 200 mL of erythrocytes.
After gentle mixing, we removed the saline by centrifugation. We repeated the saline wash, then transferred the washed cells to 250-mL bottles and centrifuged these at 8000 x g. After removing the buflr coat, we transferred the cells to a 2-L graduated cylinder.
Dried-blood spots. We combined washed erythrocytes with charcoal-treated serum to produce a whole-blood pool with a hematocrit of 55%, then added aqueous preparations Nonstandard abbreviations: T4, thyroxin; TSH, thyrotropin; Phe, phenylalanine; HSD, Tukey's "honestly significant difference";
ANOVA,
analysis of variance. 276) , labeled W52A1. We applied a 0.1-mL aliquot of each freshly prepared whole-blood pool to each of 20 ifiter paper strips per production lot, as described by Hearn and Hannon (4). We similarly applied aliquots from the hemolyzed portions of the blood pools onto 20 paired (cut from the same card) strips of ifiter paper per lot. Power calculations showed this number of samples to be sufficient to detect 5% differences among lots and among lysis treatments with 95% confidence and 95% power, assuming an analytical coefficient of variation (CV) of 10% (5). The specimens were sealed in storage bags, two specimen strips per ifiter paper lot per lysis treatment (i.e., 24 strips) per bag.
Laboratory Analysis
The (blind-coded) prepared blood-spot specimens, handling instructions, and data-report sheets were shipped to the Chemical Services Division,
Texas Department of
Health, Austin, TX, for routine analysis in their newbornscreening section by the methods mentioned above. They assayed 1/8-in, punches from each spot on the set of strips from each storage bag in each of 10 independent runs, assaying each analyte in the specimens in duplicate within the same run. Assay calibrators and quality-control materials were prepared with ifiter paper lot W41. The raw data and analytical results were reported to the Centers for Disease Control (CDC) for statistical analysis.
Statistical Analysis
We performed separate analyses for each of the three analytes.
The overall experimental design was a three-way factorial analysis of variance (ovA), with filter paper lot, lysis treatment, and pool (enriched concentration) as the three factors. All two-way and three-way interactions were also included in the model, as were analytical run and ifiterpaper strip as nested factors. If significant (P <0.05) interactions were encountered, then we performed separate twoway factorial r'ovAs at each level of the interacting factors. When significant differences among lots were indicated by ANOVA, we used Tukey's "honestly significantdifference" (HSD) tests to locate the differences (6). This method allowed pairwise differences to be determined while maintaining an overall significance level of P -0.05 for the experiment as a whole.
Linear regressions of observed analyte concentration vs enriched concentration were performed for each ifiter paper lot and lysis treatment. We used analysis of covariance to determine if there were significant differences among the slopes for all lots; if there were, we performed separate analyses of covariance on each pair of lots to locate the differences.
Because each analytical run contained strips from six different lots-with each strip being spotted with five pools to cover a range of analyte concentrations-we could examme the effect of the filter paper lot used for calibration on the measured values from specimens on other lots. For each run, we developed separate calibration curves for each lot by using recorded raw data from each pool and the corresponding known enriched concentration.
These calibration curves were then used for the analyses of all other lots in the run. For our calculations we used the observed raw data from each run-counts per minute for the radioimmunoassays (RIAs) and growth-zone diameters for the bioassay. For each pool, differences in results for all noncalibrator lots were summarized as the maximum percentage difference in concentrations due to the calibrator lot effect. The percentage differencewas defined as follows: percentage difference = 100% x (highest mean concn. -lowest mean concn.)/final concn. of enriched pool We used intact-cell pools to calibrate the results for both the intact-and lysed-cell specimens, and also used lysed-cell poolsto calibrate results for intact-cell specimens. The forms of regression used for each analyte in the calibrator analysis were as follows:
TSH and T4, logit counts/mm vs log added concentration Phe, diameter of growth zone vs log added concentration All statistical analyses were performed with SAS software (SAS Institute, Cary, NC) in an IBM 3081 mainframe computer.
Results
Serum absorbancy has been documented as an indicator of filter paper uniformity and has been shown to vary among lots (1,3). Figure 1 compares the serum-absorbancies of all lots of filter paper previously evaluated, as well as the more current lots (W54 excluded). Absorbancy values for lots W12, W13, W15, and W16 differ significantly (P <0.05) from the mean of all lots, the values for three of these four lots being below the lower 95% confidence limit.
We deleted all data from the base pools (added analyte concentration = 0) assayed for T4 and TSH because the recorded counts per minute for these pools frequently exceeded that of the assay-kit base pool (or B0). This resulted in negative observations and prohibited the calculation of logit counts per minute for the analyticalregressions used to calibrate the assays. We split the ANOVAS into several We assayed all specimens in duplicate but also re-ana- units of TSH per liter were also discretely distributed within and among lots. Thus, the resolution of these screening assays at critical concentrations-with differences of these magnitudes-seems unaffected by the filter paper lot used for specimen collection.
We found that among-lot mean measured values differed significantly in many cases. Frequently lot W12, a lot with low serum-absorbancy, yielded high observed values. However, results for this lot were usually not significantly different from results for lot W22, a lot with high serumabsorbancy. This may be explained by the statistical power of the study design, which enabled the discernment of subtle differences among lots. Also, other factors-such as paper elution characteristics-may affect analyte quantitation. We found that TSH assays, and most of the T4 assays, yielded higher measured values for intact-cell preparations than for lysed-cell preparations, which corroborates earlier findings that serum-absorbancy is generally lower when Table 2 shows that different ifiter paper lots with intactcell pools, used to calibrate the analysis of specimens on all other lots, gave maximum differences in the measured concentrations of intact-and lysed-cell specimens of 14%-22% for T4, 13%-22% for TSH, and 15%-29% for Phe. The same experiment with lysed-cell pools gave similar results for intact-cell specimen analyses ( Lysed-cell pools as calIbrators lysed-cell whole blood is applied to filter paper (authors' unpublished data) and that these analytes are associated with the serum component of the blood. Conversely, mean measured Phe values were slightly higher in some of the lysed-cell specimens than in the intact-cell specimens. Slopes for the Phe calibration curves constructed from the raw data were close to 1 for both lysed-and intact-cell preparations.
These findings are consistent with a more uniform distribution of Phe in whole blood. Conversely T4 and TSH calibration curve slopes were generally >1 for intact-cell specimens and <1 for lysed-cell specimens. The respective positive and negative proportional biases are consistent with the lower serum-absorbancy associated with lysed-cell whole-blood preparations. Positive Phe and T4 calibration curve intercepts and negative intercepts for TSH were not meaningfully different among lots and were attributed to the analytical methods selected.
We examined filter-paper lot calibration-effect to determine whether preparing assay calibrators on lots that differ from the lots used to collect specimens will bias assay results. The percentage differences found for all lots are comparable to the maximum percentage differences of the mean measured values derived from a common calibrator lot-lot W41 in this study. The serum-absorbancy of lot W41 is very close to the mean serum-absorbancy of all lots produced since 1979, thus minimizing filter-paper bias in the study findings. Lot W12 most often yielded the lowest observed values as a calibration matrix for the assay of specimens on other lots. This is inconsistent with the finding that W12 has the lowest serum-absorbancy of all lots tested. We examined printed(W52A) and unprinted samples of filter paper lot W52. Printed paper prepared for standard collection kits generally has a somewhat lower serumabsorbancy. This loss of absorbancy, most likely due to compression of the paper during printing, did not result in any real quantification differences for any analyte on that lot. However, the National Committee for Clinical Laboratory Standards suggests that all printed paper should be tested for homogeneity and comparability with the current lot(s) in use (3).
Lot-to-lot filter paper variability is demonstrated by statistically significant differences in serum-absorbancy and analyte recovery. We conclude that this variability is not solely sufficient to cause meaningful assay quantification errors that impact on the predictive value of the screening process. But not all variables that characterize screening assays, ranging from specimen quality to experimental error, are well described. The cumulative effect of these variables is hypothetical (8) . We strongly advocate that variability in ifiter paper, which is now better understood, should be controlled by limiting the number of different production lots in use at any given time and monitoring the quality of the finished specimen-collection kit. This admonition applies not only to individual statewide or regionwide screening programs, but also to national efforts to standardize the matrices used to prepare calibrators and reference materials. All variability in a screening program that can be controlled should be minimized or eliminated to avoid the misidentification of affected infants and the attendant clinical, ethical, and legal ramifications.
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